Advanced strategies to overcome multidrug resistance in cancer therapy: progress in P-glycoprotein inhibitors, drug delivery, and personalized medicine

Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21(9):3233

Article  PubMed  PubMed Central  CAS  Google Scholar 

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3(4):524

Article  PubMed Central  Google Scholar 

Duan C, Yu M, Xu J, Li BY, Zhao Y, Kankala RK (2023) Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges. Biomed Pharmacother 162:114643

Article  PubMed  CAS  Google Scholar 

Loira-Pastoriza C, Todoroff J, Vanbever R (2014) Delivery strategies for sustained drug release in the lungs. Adv Drug Deliv Rev 75:81–91

Article  PubMed  CAS  Google Scholar 

Kankala RK, Liu CG, Chen AZ, Wang SB, Xu PY, Mende LK et al (2017) Overcoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive ROS-generating nanoreactors. ACS Biomater Sci Eng 3(10):2431–2442

Article  PubMed  CAS  Google Scholar 

Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112(S1):S92-107

Article  PubMed  PubMed Central  Google Scholar 

Li T, Li J, Chen Z, Zhang S, Li S, Wageh S et al (2022) Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions. J Controlled Release 352:338–370

Article  CAS  Google Scholar 

Husain A, Makadia V, Valicherla GR, Riyazuddin M, Gayen JR (2022) Approaches to minimize the effects of P-glycoprotein in drug transport: a review. Drug Dev Res 83(4):825–841

Article  PubMed  CAS  Google Scholar 

Wright SCE, Vasilevski N, Serra V, Rodon J, Eichhorn PJA (2021) Mechanisms of resistance to PI3K inhibitors in cancer: adaptive responses, drug tolerance and cellular plasticity. Cancers 13(7):1538

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S et al (2022) Multidrug resistance of cancer cells and the vital role of P-glycoprotein. Life 12(6):897

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goyal R, Kaur G, Malik DS, Singh S, Dua K, Singh D et al (2025) Assessing anti-acne potentials via in vitro, ex vivo, and in vivo models: a comprehensive approach. Curr Drug Targets 26(7):435–453

Article  PubMed  CAS  Google Scholar 

Estevinho MM, Fernandes C, Silva JC, Gomes AC, Afecto E, Correia J et al (2022) Role of ATP-binding cassette transporters in sorafenib therapy for hepatocellular carcinoma: an overview. Curr Drug Targets 23(1):21–32

Article  PubMed  CAS  Google Scholar 

Davis LN, Sherbenou DW (2021) Emerging therapeutic strategies to overcome drug resistance in multiple myeloma. Cancers 13(7):1686

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kankala RK, Tsai PY, Kuthati Y, Wei PR, Liu CL, Lee CH (2017) Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics. J Mater Chem B 5(7):1507–1517

Article  PubMed  CAS  Google Scholar 

Whittle EE, Orababa O, Osgerby A, Siasat P, Element SJ, Blair JMA et al (2024) Efflux pumps mediate changes to fundamental bacterial physiology via membrane potential. Wright GD, editor. mBio 15(10):e02370-24

Article  PubMed  PubMed Central  Google Scholar 

Engle K, Kumar G (2022) Cancer multidrug-resistance reversal by ABCB1 inhibition: a recent update. Eur J Med Chem 239(Sep):114542

Article  PubMed  CAS  Google Scholar 

Hu X, Zhang Z (2016) Understanding the genetic mechanisms of cancer drug resistance using genomic approaches. Trends Genet 32(2):127–137

Article  PubMed  CAS  Google Scholar 

Zhang A, Miao K, Sun H, Deng CX (2022) Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci 18(7):3019–3033

Article  PubMed  PubMed Central  CAS  Google Scholar 

Long W, Zhang L, Wang Y, Xie H, Wang L, Yu H (2022) Research progress and prospects of autophagy in the mechanism of multidrug resistance in tumors. Zheng D, editor. J Oncol 2022:1–15

Google Scholar 

Vaidya FU, Sufiyan Chhipa A, Mishra V, Gupta VK, Rawat SG, Kumar A et al (2022) Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Rep 5(12):e1291

CAS  Google Scholar 

Dong J, Yuan L, Hu C, Cheng X, Qin JJ (2023) Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review. Pharmacol Ther 249:108488

Article  PubMed  CAS  Google Scholar 

Huang J, Ecker GF (2023) A structure-based view on ABC-transporter linked to multidrug resistance. Molecules 28(2):495

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu CP, Hsiao SH, Wu YS (2023) Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2. Drug Resist Updat 71:101011

Article  PubMed  CAS  Google Scholar 

Hanssen KM, Haber M, Fletcher JI (2021) Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: beyond pharmacological inhibition. Drug Resist Updat 59(Dec):100795

Article  PubMed  CAS  Google Scholar 

Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293–303

Article  PubMed  Google Scholar 

Burnstock G, Di Virgilio F (2013) Purinergic signalling and cancer. Purinergic Signal 9(4):491–540

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kroll T, Prescher M, Smits SHJ, Schmitt L (2021) Structure and function of hepatobiliary ATP binding cassette transporters. Chem Rev 121(9):5240–5288

Article  PubMed  CAS  Google Scholar 

Andreoletti P, Raas Q, Gondcaille C, Cherkaoui-Malki M, Trompier D, Savary S (2017) Predictive structure and topology of peroxisomal ATP-binding cassette (ABC) transporters. Int J Mol Sci 18(7):1593

Article  PubMed  PubMed Central  Google Scholar 

Mora Lagares L, Pérez-Castillo Y, Minovski N, Novič M (2021) Structure–function relationships in the human P-glycoprotein (ABCB1): insights from molecular dynamics simulations. Int J Mol Sci 23(1):362

Article  PubMed  PubMed Central  Google Scholar 

Alam A, Küng R, Kowal J, McLeod RA, Tremp N, Broude EV, et al. Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc Natl Acad Sci [Internet]. 2018 Feb 27 [cited 2025 Jun 26];115(9). Available from: https://pnas.org/doi/full/https://doi.org/10.1073/pnas.1717044115

Dunk CE, Pappas JJ, Lye P, Kibschull M, Javam M, Bloise E et al (2018) P-glycoprotein (P-gp)/ ABCB 1 plays a functional role in extravillous trophoblast ( EVT ) invasion and is decreased in the pre-eclamptic placenta. J Cell Mol Med 22(11):5378–5393

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gaohua L, Miao X, Dou L (2021) Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity. Expert Opin Drug Metab Toxicol 17(9):1103–1124

Comments (0)

No login
gif